Meridian Bioscience Inc FDA Record
- Latest inspection NAI · Nov 17, 2017
- Last warning letter 2025
Meridian Bioscience Inc has 15 FDA recalls, 3 inspections, 38 510(k) clearances and 0 compliance actions on record. FDA has issued 1 warning letter to Meridian Bioscience Inc, the most recent on Dec 22, 2025.
- Latest recall
- Z-1019-2026 · Class II · Dec 5, 2025
- Latest inspection
- Nov 17, 2017 · NAI
- Latest 510(k)
- Mar 20, 2025
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 15 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 38 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 3 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Meridian Bioscience Inc: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 3 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 3 | 0 |
| 2022 | 0 | 0 | 0 | 3 | 0 |
| 2021 | 0 | 0 | 0 | 3 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 1 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Meridian Bioscience Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Meridian Bioscience Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Meridian Bioscience Inc FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Dec 22, 2025 · Letter on fda.gov | CGMP/QSR/Medical Devices/Adulterated | Center for Devices and Radiological Health |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-1019-2026 | Class II | Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument… | Dec 5, 2025 |
| Z-0569-2026 | Class II | Meridian Bioscience, Group B Streptococcus, Catalog Number 480050, Nucleic Acid Amplification Test… | Oct 7, 2025 |
| Z-0568-2026 | Class II | Meridian Bioscience, alethia c. Difficile, Catalog Number 480050, Nucleic Acid Amplification Test… | Oct 7, 2025 |
| Z-0520-2024 | Class II | Para-Pak Zn-PVA/10% Formalin-for the routine collection, transportation, preservation, and… | Oct 19, 2023 |
| Z-0519-2024 | Class II | Para-Pak Clean Vial-For the collection, transportation, preservation, and examination of stool… | Oct 19, 2023 |
| Z-0521-2024 | Class II | Cardinal Health Clean Stool Transportation System-For the collection, transportation, preservation… | Oct 19, 2023 |
| Z-1008-2023 | Class II | Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from… | Dec 15, 2022 |
| Z-1479-2022 | Class II | Revogene, Catalog no. 610210. IVD test instrument | Jun 22, 2022 |
| Z-0836-2022 | Class II | Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical laboratories… | Feb 15, 2022 |
| Z-1540-2021 | Class II | Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase… | Apr 8, 2021 |
| Z-1541-2021 | Class II | Revogene RNA Software Upgrade Kit Revogene RNA Software Upgrade USBs Catalog Number: 610240 IVD… | Apr 8, 2021 |
| Z-1299-2021 | Class II | The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usage… | Feb 8, 2021 |
| Z-0732-2019 | Class II | PREMIER Cryptococcal Antigen, Catalog Number 602096 Product Usage: The PREMIER Cryptococcal… | Dec 17, 2018 |
| Z-1033-2017 | Class II | PREMIER EHEC and PREMIER EHEC Bulk. | Nov 8, 2016 |
| Z-1941-2014 | Class II | illumipro-10 Incubator/Reader, Meridian Bioscience, Inc. The illumipro-10 incubator/reader is… | Apr 22, 2014 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 17, 2017 | Cincinnati, OH | Devices | No Action Indicated (NAI) | 1524213 |
| Jun 12, 2014 | Cincinnati, OH | Devices | No Action Indicated (NAI) | 1524213 |
| Mar 21, 2013 | Cincinnati, OH | Devices | No Action Indicated (NAI) | 1524213 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 1524213 | Cincinnati, OH | 3 | Nov 17, 2017 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K243922 | Revogene | Mar 20, 2025 |
| K230901 | Premier HpSA Flex (619096) | Jul 3, 2023 |
| K222829 | Curian® Shiga Toxin | Apr 17, 2023 |
| K222779 | Revogene | Jan 26, 2023 |
| K220480 | Revogene | Jul 11, 2022 |
| K210976 | Curian Campy | Dec 23, 2021 |
| K192817 | Curian HpSA, Curian Analyzer | Mar 13, 2020 |
| DEN180040 | Alethia CMV DNA Amplification Assay, Alethia CMV External Control Kit | Nov 30, 2018 |
| K182559 | PREMIER Platinum HpSA PLUS | Nov 5, 2018 |
| K163273 | TRU Legionella | Feb 21, 2017 |
| K160829 | illumigene Mycoplasma Direct DNA Amplification Assay, illumigene Mycoplasma Direct External… | Jun 13, 2016 |
| K153661 | ImmunoCard STAT! HpSA | Mar 14, 2016 |
| K152285 | illumigene Pertussis DNA Amplification Assay | Nov 10, 2015 |
| K152800 | illumigene Mycoplasma DNA Amplification Assay | Oct 23, 2015 |
| K151046 | illumigene HSV 1&2 DNA Amplification Assay, illumigene HSV 1&2 External Control Kit, illumipro-10 | Jul 17, 2015 |
| K133673 | ILLUMIGENE PERTUSIS DNA AMPLIFICATION ASSAY, ILLUMIGENE PERTUSSIS EXTERNAL CONTROL KIT, ILLUMIPRO-10… | Mar 25, 2014 |
| K133714 | TRU FLU | Jan 3, 2014 |
| K123423 | ILLUMIGENE MYCOPLASAMA DNA AMPLIFICATION ASSAY, AND ILLUMIGENE MYCOPLASMA EXTERNAL CONTROLS KIT | Jun 5, 2013 |
| K122019 | STREPTOCOCCUS APP. SEROLOGICAL REAGENTS | Sep 13, 2012 |
| K121044 | ILLUMIGENE GROUP B STREPTOCOCCUS CARROT BROTH CLAIM | May 1, 2012 |
Meridian Bioscience Inc and the FDA: common questions
Has Meridian Bioscience Inc received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Meridian Bioscience Inc. The most recent is dated Dec 22, 2025, with the subject "CGMP/QSR/Medical Devices/Adulterated".
Has Meridian Bioscience Inc received an FDA Form 483?
FDA has not published a Form 483 for "Meridian Bioscience Inc" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Meridian Bioscience Inc?
The most recent FDA inspection on file ended Nov 17, 2017 at Cincinnati, OH and was classified NAI. FDA has 3 inspections of Meridian Bioscience Inc on file.
Has Meridian Bioscience Inc had an FDA recall?
Yes. Meridian Bioscience Inc has 15 FDA recalls on record. The most recent started Dec 5, 2025.
Need more than this page shows? Ask about Meridian Bioscience Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.